Corporate Overview

Shuttle Pharmaceuticals (Nasdaq: SHPH) is a clinical-stage pharmaceutical company leveraging our proprietary technology to develop novel therapies that are designed to cure cancer. Our goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy. Radiation therapy (RT) is among the most effective and proven treatment modalities for curing cancers.

The Company has developed technologies to sensitize growing cancer cells, rendering them susceptible to the effects of radiation therapy, and activate the DNA damage response pathway to kill cancer cells and protect adjacent normal cells. In addition, the Company’s in-licensed diagnostic tests and theranostic molecules offer to enhance staging and treatment of prostate cancers.

Recent News

Company​

Shuttle Pharmaceuticals
401 Professional Drive, Suite 260
Gaithersburg, MD 20879
Phone: 240-430-4212

Email: info@shuttlepharma.com

Investor Relations

Lytham Partners, LLC
Robert Blum
Phone: 602-889-9700

Email: shph@lythampartners.com